“Most respondents advocated for the wider use of telehealth and online platforms for post-treatment survivorship follow-up after the pandemic is resolved. Other suggestions to improve care after the pandemic included the routine use of virtual exams to observe images (e.g., mammography, CT scan), and the use of effective triaging of survivors’ needs over the phone, as well as strategies to improve the acceptability of telehealth among patients (such as the use of telehealth only after the first face-to-face appointment).”

This article, “Cancer survivorship care during COVID-19 – perspectives and recommendations from the MASCC survivorship study group,” was co-authored by our Chief Scientific Officer, Dr. Fred Ashbury. The VieCure platform includes remote patient monitoring and telehealth capabilities to provide practices with the tools to facilitate these new methods of engagement and as a tool to provide access to new revenue streams during these changing times.

Cancer survivorship care 

during COVID-19 - perspectives and recommendations from the MASCC survivorship study group

May 25, 2020

Alexandre Chen, Fred Ashbury, Margaret I Fitch, Bodga Koczwara, Raymond Javan Chan, MASCC Survivorship Study Group

AdobeStock_274271972.jpeg

4949 South Syracuse Street, Suite 450, Denver, CO 80237

  • LinkedIn
  • Facebook

Copyright © 2020 VieCure. All Rights Reserved